Ber 2012 Accepted: 12 November 2013 Published: 27 NovemberQuartin et al. BMC Infectious Ailments 2013, 13:561 http://biomedcentral/1471-2334/13/Page six ofReferences 1. American Thoracic Society: Infectious Illnesses Society of America: suggestions for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171(4):388?16. two. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS: Epidemiology and outcomes of health-care-associated pneumonia: outcomes from a sizable US database of culture-positive pneumonia.[Erratum seems in Chest. 2006 Mar;129(3):831]. Chest 2005, 128(6):3854?862. 3. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH: Overall health care-associated pneumonia and community-acquired pneumonia: a single-center practical experience. Antimicrob Agents Chemother 2007, 51(ten):3568?573. four. Shorr AF, Zilberberg MD, Micek ST, Kollef MH: Prediction of infection because of antibiotic-resistant bacteria by choose threat things for wellness care-associated pneumonia. Arch Intern Med 2008, 168(20):2205?210. 5. Zilberberg MD, Shorr AF, Micek ST, Mody SH, Kollef MH: Antimicrobial therapy escalation and hospital mortality amongst patients with health-careassociated pneumonia: a single-center encounter. Chest 2008, 134(five):963?68. 6. Madaras-Kelly KJ, Remington RE, Fan VS, Sloan KL: Predicting antibiotic resistance to community-acquired pneumonia antibiotics in culture-positive sufferers with healthcare-associated pneumonia.4-(Methylsulfinyl)aniline Formula J Hosp Med 2012, 7(three):195?02.Buy2,3,4,5,6-Pentafluoroaniline 7.PMID:23800738 Attridge RT, Frei CR, Restrepo MI, Lawson KA, Ryan L, Pugh MJV, Anzueto A, Mortensen EM: Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur Respir J 2011, 38(four):878?87. 8. Webb BJ, Dangerfield BS, Pasha JS, Agrwal N, Vikram HR: Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia. Respir Med 2012, 106(11):1606?612. 9. Jung JY, Park MS, Kim YS, Park BH, Kim SK, Chang J, Kang YA: Healthcare-associated pneumonia amongst hospitalized individuals within a Korean tertiary hospital. BMC Infect Dis 2011, 11:61. ten. Seki M, Hashiguchi K, Tanaka A, Kosai K, Kakugawa T, Awaya Y, Kurihara S, Izumikawa K, Kakeya H, Yamamoto Y, et al: Qualities and disease severity of healthcare-associated pneumonia among patients in a hospital in Kitakyushu, Japan. J Infect Chemother 2011, 17(3):363?69. 11. Sugisaki M, Enomoto T, Shibuya Y, Matsumoto A, Saitoh H, Shingu A, Narato R, Nomura K: Clinical characteristics of healthcare-associated pneumonia in a public hospital in a metropolitan location of Japan. J Infect Chemother: official journal in the Japan Society of Chemotherapy 2012, 18(3):352?60. 12. Giannella M, Pinilla B, Capdevila JA, Martinez Alarcon J, Munoz P, Lopez Alvarez J, Bouza E: Pneumonia treated within the internal medicine division: focus on healthcare-associated pneumonia. Clin Microbiol Infec: the official publication with the European Society of Clinical Microbiology and Infectious Illnesses 2012, 18(eight):786?94. 13. Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Shiraki A, Goto Y, Fukui Y, Iwaki M, Okumura J, et al: Danger things for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med 2013, 188(eight):985?95. 14. Ma HM, Ip M, Woo J, Hui DS, Lui GC, Lee NL, Chan PK, Rainer TH: Danger factors for drug-resistant bacterial pneumonia in older individuals hospitalized with pneumonia in a Chinese population. QJM 2013, 106(9):823.